![](/img/cover-not-exists.png)
A268 Phase I/II Trial of Lenalidomide, Bortezomib, Doxil, and Dexamethasone in Front-Line Multiple Myeloma
Jakubowiak, AJ, Hofmeister, C, Campagnaro, E, Kendall, T, Zimmerman, T, Schlossman, R, Reece, D, Lonial, S, Hari, M, Hector-Word, Z, Griffith, K, Tendler, C, Esseltine, DL, Bock, T, Kaminski, M, DollaVolume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70527-3
Date:
February, 2009
File:
PDF, 108 KB
english, 2009